|
NRG-BR005 A Phase II Trial Assessing the Accuracy of Tumor Bed Biopsies in Predicting Pathologic Response in Patients with Clinical/Radiologic Complete Response after Neoadjuvant Chemotherapy in Order to Explore the Feasibility of Breast Conserving Treatment Without Surgery
At the request of the NCI, NRG Oncology is terminating/permanently closing the NRG-BR005 study effective December 1, 2022.
Please refer to the memorandum, dated December 2, 2022, posted on CTSU for more information.
| 
